440 related articles for article (PubMed ID: 9618443)
1. Nontypeable Haemophilus influenzae: pathogenesis and prevention.
Foxwell AR; Kyd JM; Cripps AW
Microbiol Mol Biol Rev; 1998 Jun; 62(2):294-308. PubMed ID: 9618443
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.
Winter LE; Barenkamp SJ
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768669
[TBL] [Abstract][Full Text] [Related]
3. Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models.
Hong W; Peng D; Rivera M; Gu XX
Microbes Infect; 2010 Jan; 12(1):11-8. PubMed ID: 19782149
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.
Kennedy BJ; Novotny LA; Jurcisek JA; Lobet Y; Bakaletz LO
Infect Immun; 2000 May; 68(5):2756-65. PubMed ID: 10768970
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media.
Hong W; Mason K; Jurcisek J; Novotny L; Bakaletz LO; Swords WE
Infect Immun; 2007 Feb; 75(2):958-65. PubMed ID: 17130253
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx.
Kyd JM; Cripps AW; Novotny LA; Bakaletz LO
Infect Immun; 2003 Aug; 71(8):4691-9. PubMed ID: 12874350
[TBL] [Abstract][Full Text] [Related]
7. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.
Poolman JT; Bakaletz L; Cripps A; Denoel PA; Forsgren A; Kyd J; Lobet Y
Vaccine; 2000 Dec; 19 Suppl 1():S108-15. PubMed ID: 11163473
[TBL] [Abstract][Full Text] [Related]
8. Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.
Duell BL; Su YC; Riesbeck K
FEBS Lett; 2016 Nov; 590(21):3840-3853. PubMed ID: 27508518
[TBL] [Abstract][Full Text] [Related]
9. Unraveling Haemophilus influenzae virulence mechanisms enable discovery of new targets for antimicrobials and vaccines.
Langereis JD; de Jonge MI
Curr Opin Infect Dis; 2020 Jun; 33(3):231-237. PubMed ID: 32304471
[TBL] [Abstract][Full Text] [Related]
10. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
[TBL] [Abstract][Full Text] [Related]
11. A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
Whitby PW; Morton DJ; Mussa HJ; Mirea L; Stull TL
Vaccine; 2020 Mar; 38(14):2960-2970. PubMed ID: 32111525
[TBL] [Abstract][Full Text] [Related]
12. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media.
Langereis JD; Stol K; Schweda EK; Twelkmeyer B; Bootsma HJ; de Vries SP; Burghout P; Diavatopoulos DA; Hermans PW
mBio; 2012; 3(4):e00079-12. PubMed ID: 22761391
[TBL] [Abstract][Full Text] [Related]
13. Why we need a vaccine for non-typeable Haemophilus influenzae.
Cerquetti M; Giufrè M
Hum Vaccin Immunother; 2016 Sep; 12(9):2357-61. PubMed ID: 27171854
[TBL] [Abstract][Full Text] [Related]
14. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
[TBL] [Abstract][Full Text] [Related]
15. Sialic Acid Protects Nontypeable Haemophilus influenzae from Natural IgM and Promotes Survival in Murine Respiratory Tract.
Jackson MD; Wong SM; Akerley BJ
Infect Immun; 2021 May; 89(6):. PubMed ID: 33782153
[TBL] [Abstract][Full Text] [Related]
16. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media.
DeMaria TF; Murwin DM; Leake ER
Infect Immun; 1996 Dec; 64(12):5187-92. PubMed ID: 8945564
[TBL] [Abstract][Full Text] [Related]
17. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274.
Ueyama T; Gu XX; Tsai CM; Karpas AB; Lim DJ
Clin Diagn Lab Immunol; 1999 Jan; 6(1):96-100. PubMed ID: 9874671
[TBL] [Abstract][Full Text] [Related]
18. [Progress toward molecular determinants of the pathogenesis of disease due to nontypeable Haemophilus influenzae].
Tian GZ; Zhang L; Shao ZJ
Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):174-9. PubMed ID: 20077666
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.
Sun J; Chen J; Cheng Z; Robbins JB; Battey JF; Gu XX
Vaccine; 2000 Jan; 18(13):1264-72. PubMed ID: 10649628
[TBL] [Abstract][Full Text] [Related]
20. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
